TOP STORIES

• COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
  August 27, 2025

• REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
  August 27, 2025

• REGULATORY MHLW Seeks New R&D Tax Credit Scheme for Strategic Technologies in FY2026 Proposal
  August 27, 2025

• REGULATORY Japan Approves 3 New Drugs, Expands Label for Enhertu, Silgard 9 and More
  August 26, 2025

• BUSINESS Meiji Revives Penicillin Raw Material Production in Japan after 31 Years, Races to Pass Down Know-How
  August 26, 2025

• BUSINESS Astellas CFO Outlines Cost Cuts, Licensing Push as Xtandi Nears Patent Cliff
  August 25, 2025

• REGULATORY Novartis’ Radioligand Therapy, More Meds Inch Closer to Japan Approval with Panel OK
  August 25, 2025

• REGULATORY PMDA’s “Early Considerations” Start to Pay Off with Faster Reviews
  August 22, 2025

• REGULATORY Japan Mulls Preferential R&D Tax Credits for Strategic Technologies in FY2026 Reform Talks
  August 22, 2025

• ORGANIZATION Hemp Cannabinoid Consortium Draws 40 Inquiries from Industry and Academia
  August 22, 2025

• BUSINESS Linepharma Japan Eyes Ophthalmology as Second Pillar to Women’s Health
  August 22, 2025

• REGULATORY AMED to Put Practicality First in Project Selection: Ecosystem Coordinator
  August 21, 2025

• BUSINESS Itochu Launches J-STEP to Help Overseas Drug Makers Tackle Japan’s “Drug Loss”
  August 21, 2025

• BUSINESS Alloy Japan Looks to Turn iCAR-T into Shared Infrastructure, IND Filing Slated for 2026
  August 20, 2025

• BUSINESS Keytruda Retains Top Spot in Japan Drug Market in April-June: IQVIA
  August 20, 2025

• REGULATORY Japan Weighs Legal Framework for Pharmaceutical Data Protection; JPMA Sees Opportunity for Reform
  August 19, 2025

• REGULATORY Japan Approves First SGLT2 Generics, 12 Firms Pile into Vimpat Ahead of December Listing
  August 18, 2025

• REGULATORY Novartis’ Radioligand Therapy, Other New Meds Up for Japan Panel Review on Aug. 22
  August 12, 2025

• REGULATORY Japan Nears Approval for 1st Biosimilars of Actemra, Simponi, and Ranmark
  August 12, 2025

• REGULATORY Japan Approves FY2026 Budget Guidelines, Natural Increase at 400 Billion Yen
  August 12, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• …
• Next ›
• 最終 »